A Comparison of Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients.

Trial Profile

A Comparison of Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Dec 2013

At a glance

  • Drugs Aprepitant (Primary) ; Dexamethasone (Primary) ; Ondansetron (Primary)
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Oct 2011 Results presented at the 2011 Annual Meeting of the American Society of Anesthesiologists.
    • 12 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top